参考文献/References:
[1] Roman SA.Endocrine tumors:evaluation of the thyroid nodule.Curt Opin Oncol,2003,15(1):66-70.
[2] 张永学.核医学.北京:人民卫生出版社,2005.254-259.
[3] Maki K,Okumura Y,Sato S,et al.Quantitative evaluation by Tl-201 scintigraphy in the diagnosis of thyroid follicular nodules.Ann Nucl Med,2003,17(2):91-98.
[4] 余永利,于建芳,朱瑞森.半定量法201Tl双时相显像鉴别诊断甲状腺冷结节.核技术,2002,25(11):969-972.
[5] 冯国伟,杨忠毅,田伟家,管樑.99mTc-甲氧基异丁基异腈双时相核素显像对甲状腺结节良、恶性鉴别的价值探讨.内科理论与实践,2008,3(3):186-187.
[6] Küζük ON,Gultekin SS,Aras G,et al.Radioiodine whole-body scans,thyroglobulin levels,99mTc-MIBI scans and computed tomography:results in patients with lung metastases from differentiated thyroid cancer.Nucl Med Commun,2006,27(3):261-266.
[7] Hurtado-Lopez LM,Martinez-Duncker C.Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules.Eur J Nucl Med Mol Imaging,2007,34(10):1701-1703.
[8] Tamizu A,Okumura Y,Sato S,et al.The usefulness of serum thyroglobulin levels and T1-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions.Ann Nucl Med,2002,16(2):95-101.
[9] Hardoff R,Baron E,Sheinfeld M.Early and late lesion to nonlesion ratio of thallium-201 chloride uptake in the evaluation of cold thyroid nodules.J Nucl Med,1991,32(10):1873-1876.
[10] 丁明辉,张宝牛,刘炯,等.99mTc-MIBI和99mTc(V)-DMSA乳腺肿物显像的比较研究.山西医药杂志,2004,33(11):945-945.
[11] Ugur O,Kestakglu L,Guler N,et al.Comparison of 99mTc(V)-DMSA,201TI and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.Eur J Nucl Med,1996,23(10):1367-1371.
[12] 邓波,肖欢,陈小凤,等.99Tcm(V)-DMSA与99Tcm-MIBI亲肿瘤显像在诊断甲状腺髓样癌中的对比.同位素,2004,17(1):62-64.
[13] Bohuslavizki KH.Somatosatin receptor imaging:current status and future perspectives.J Nucl Med,2001,42(7):1057-1058.
[14] Behr TM,Gotthardt M,Barth A,et al.Imaging tumors with peptidebased radioligands.Q J Nucl Med.2001,45(2):189-200.
[15] 武凤玉,左书耀.放射性核素标记奥曲肽肿瘤受体显像研究进展.国外医学:肿瘤学分册,2005,32(10):760-763.
[16] 谢新立,韩星敏,阮翘,程兵,刘保平.99Tcm-HL91乏氧显像在甲状腺结节良恶性鉴别诊断中的应用.中华核医学杂志,2008,28(2):103-105.
[17] 谭建.核医学在甲状腺癌诊断和治疗中的应用.中国实用内科杂志,2007,27(17):1339-1342.
[18] Al-Nahhas A,Khan S,Goqbashian A,et al.Review.18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.In Vivo,2008,22(1):109-114.
[19] Macapinlac HA.FDG-PET in head and neck,and thyroid cancer.Chang Gang Med J,2005,28(5):284-295.
相似文献/References:
[1]李盼丽,宋少莉.碘难治性分化型甲状腺癌靶向药物治疗进展[J].国际放射医学核医学杂志,2016,40(3):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
Li Panli,Song Shaoli.Radioactive iodine refractory differentiated thyroid cancer targeted therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
[2]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[3]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[4]刘斌,潘明志.BRAF基因突变对甲状腺乳头状癌诊治价值的研究进展[J].国际放射医学核医学杂志,2015,39(2):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
Liu Bin,Pan Mingzhi.Advances in value of BRAF gene mutation on the diagnosis and treatment of papillary thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
[5]胡斌,王锦锋,毛秋粉.18F-FDG PET/CT显像在Tg阳性131I全身显像阴性的分化型甲状腺癌患者中的应用价值[J].国际放射医学核医学杂志,2015,39(3):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
Hu Bin,Wang Jinfeng,Mao Qiufen.The application value of 18F-FDG PET/CT in patients with differentiated thyroid cancer of high thyroglobulin level and negative 131I whole body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
[6]刘鹏杰,唐铭,邓智勇,等.131I治疗儿童分化型甲状腺癌期间出现低钙血症伴癫痫发作一例[J].国际放射医学核医学杂志,2015,39(4):352.[doi:10.3760/cma.j.issn.1673-4114.2015.04.017]
[7]寇莹,刘建中,郝新忠,等.甲状腺癌131I治疗后全身扫描盆腔浓聚131I的临床分析[J].国际放射医学核医学杂志,2014,38(1):15.[doi:10.3760/cma.j.issn 1673-4114.2014.01.004]
Kou Ying,Liu Jianzhong,Hao Xinzhong,et al.Analysis of pelvic 131I uptake after 131I whole body scan in patients with thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):15.[doi:10.3760/cma.j.issn 1673-4114.2014.01.004]
[8]李敬彦,蒋宁一.分化型甲状腺癌术后131I清甲治疗方法的相关问题[J].国际放射医学核医学杂志,2014,38(1):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
Li Jingyan,Jiang Ningyi.Issues related to radioactive iodine ablation in patients with differentiated thyroid carcinoma under-going thyroid surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
[9]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[10]成钊汀,谭建.分化型甲状腺癌术后患者131I治疗的辐射剂量与防护[J].国际放射医学核医学杂志,2014,38(2):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
Cheng Zhaoting,Tan Jian.Radiation dose and protection of differentiated thyroid carcinoma postoperative patients with 131I treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
[11]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[12]龙再颖,曲新艳,单英丽.99Tcm-MIBI显像对甲状腺结节良恶性鉴别诊断价值的研究[J].国际放射医学核医学杂志,2010,34(2):80.[doi:10.3760/cma.j.issn.1673-4114.2010.02.004]
LONG Zai-ying,QU Xin-yan,SHAN Ying-li.The diagnostic value of 99Tcm-MIBI imaging to benign and malignant thyroid lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):80.[doi:10.3760/cma.j.issn.1673-4114.2010.02.004]
[13]胡旻,刘雅洁,许小飞,等.99Tcm-MIBI动态血流灌注显像和双时相核素显像对甲状腺冷结节良恶性的诊断价值研究[J].国际放射医学核医学杂志,2010,34(3):174.
HU Min,LIU Ya-jie,XU Xiao-fei,et al.Study on the diagnostic value of 99Tcm-MIBI dynamic blood flow perfusion imaging and double-phase radionuclide imaging in benign and malignant cold thyroid nodules[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):174.
[14]李昊颖.18F-氟脱氧葡萄糖PET全身显像时甲状腺意外瘤的检出及价值[J].国际放射医学核医学杂志,2007,31(3):148.
LI Hao-ying.The value of whole body 18F-fluorodeoxyglucose PET in detecting thyroid incidentaloma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):148.